apoptosis

May 23, 2016May 23, 2016

Action of BET Inhibitors, a Potential and Promising Lymphoma Drug Class, Seen in Study

News

Researchers studying the mechanism of action of BET inhibitors, drugs thought to be of promise in treating blood cancers such as leukemia and lymphoma, report discovering not only how these drugs kill cancer cells but ... Read more

March 14, 2016March 14, 2016

Lymphoma Study Sees Early Promise in Pathway Targeting Cancerous B-Cells

News

Wistar Institute researchers recently discovered that a protein in the endoplasmic reticulum, called STING, can stimulate the immune system to kill malignant B-cells — the cause of several lymphomas. The ... Read more

February 12, 2016February 12, 2016

New Compounds Seen to Kill Lymphoma/Leukemia Cells via Tumor Suppressor Pathway

News

Researchers at Roswell Park Cancer Institute (RPCI) have identified a new class of small-molecule compounds that activate the pro-death function of a known tumor suppressor pathway, causing lymphoma and leukemia cells to die. The ... Read more